Deutsche Bank AG Lowers Holdings in DaVita Inc. (NYSE:DVA)

Key Points

• Deutsche Bank AG reduced its holdings in DaVita Inc. by 7.4% in the first quarter, owning approximately 363,485 shares after selling 28,937 shares, amounting to a value of $55.6 million.
• Multiple hedge funds have made adjustments to their positions in DaVita, with Wellington Management Group LLP increasing their stake by 9.1% during the fourth quarter.
• DaVita's stock price was reported at $129.22, with a recent earnings report showing an EPS of $2.95, exceeding estimates and representing a 6.1% year-over-year revenue increase.

Deutsche Bank AG trimmed its position in DaVita Inc. (NYSE:DVA - Free Report) by 7.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 363,485 shares of the company's stock after selling 28,937 shares during the quarter. Deutsche Bank AG owned 0.47% of DaVita worth $55,602,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Wellington Management Group LLP lifted its stake in shares of DaVita by 9.1% during the 4th quarter. Wellington Management Group LLP now owns 2,711 shares of the company's stock worth $405,000 after purchasing an additional 227 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in DaVita in the fourth quarter valued at about $3,864,000. BTG Pactual Asset Management US LLC purchased a new stake in DaVita in the fourth quarter valued at about $225,000. Trustmark National Bank Trust Department raised its stake in DaVita by 36.7% in the fourth quarter. Trustmark National Bank Trust Department now owns 2,511 shares of the company's stock valued at $376,000 after buying an additional 674 shares during the last quarter. Finally, Mariner LLC increased its holdings in shares of DaVita by 3.8% in the fourth quarter. Mariner LLC now owns 6,438 shares of the company's stock valued at $963,000 after purchasing an additional 233 shares during the period. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on DVA. Wall Street Zen raised DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. Barclays cut their price objective on DaVita from $169.00 to $160.00 and set an "equal weight" rating on the stock in a report on Thursday, August 7th. Finally, Truist Financial set a $148.00 price objective on DaVita in a report on Friday.

Insider Buying and Selling

In related news, insider James O. Hearty sold 2,351 shares of the firm's stock in a transaction dated Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total transaction of $352,650.00. Following the sale, the insider directly owned 26,038 shares of the company's stock, valued at $3,905,700. This trade represents a 8.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.50% of the stock is currently owned by company insiders.

DaVita Stock Down 0.2%

DaVita stock opened at $129.22 on Tuesday. The firm has a market cap of $9.24 billion, a price-to-earnings ratio of 12.71, a price-to-earnings-growth ratio of 0.93 and a beta of 1.09. DaVita Inc. has a 52 week low of $126.07 and a 52 week high of $179.60. The business's 50-day moving average price is $139.92 and its 200 day moving average price is $146.19. The company has a quick ratio of 1.34, a current ratio of 1.39 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $2.95 EPS for the quarter, topping the consensus estimate of $2.70 by $0.25. The firm had revenue of $3.38 billion for the quarter, compared to analyst estimates of $3.36 billion. DaVita had a return on equity of 369.39% and a net margin of 6.35%. DaVita's revenue for the quarter was up 6.1% compared to the same quarter last year. During the same period last year, the company earned $2.00 earnings per share. As a group, sell-side analysts anticipate that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.